Zentalis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Update
Closed initial public offering (IPO) of common stock, raising gross proceeds of ~$190.0 millionNEW YORK and SAN DIEGO, Aug. 13, […]
Closed initial public offering (IPO) of common stock, raising gross proceeds of ~$190.0 millionNEW YORK and SAN DIEGO, Aug. 13, […]
– Upsized IPO in June 2020 raised $244.4 million in gross proceeds –Bay Street News
Prolonged Covid-19 status leads to emphasis on product enhancementsConference call to be held today at 9:00 a.m. EDTBOCA RATON, Fla., […]
TEL AVIV, Israel, Aug. 13, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) today announced financial results for the second […]
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the […]
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions […]
MORTON GROVE, Ill., Aug. 13, 2020 (GLOBE NEWSWIRE) — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading […]
LEXINGTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]
Dosed First Patient in Phase 1/2a Clinical Trial of PBCAR269A, a BCMA-Targeted Allogeneic CAR T Candidate for Multiple MyelomaPBCAR0191 and […]
NEW YORK and VIENNA, Austria, Aug. 13, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]